Vascular stiffening, a process responsible for the development of isolated systolic hypertension, depends on dysregulation of collagen-elastine production and arrangement, yet it is not known whether the effect is uniform throughout wide blood pressure (BP) range. To check whether arterial stiffness is similarly related to increased fibrotic remodelling, in patients with systolic blood pressure (SBP) above and below 160 mmHg. Consecutive peri-and postmenopausal female outpatients treated for hypertension and free from other disorders interfering with fibrotic processes, had their BP, pulse wave velocity (PWV), and collagen (N-terminal procollagen type III propeptide (PIIINP); C-terminal procollagen type I propeptide-(PICP)) measured. The average age of 100 women was 71.8710.5 years, BP was 145/83725/15 mmHg, pulse pressure 63717 mmHg, and mean blood pressure (MBP) 104717 mmHg. PWV was 12.973.6 m/s and was significantly higher among 30 patients with SBP of X160 mmHg. PIIINP averaged 4.671.6 ng/ml and PICP 142.2747.0 ng/ml. In the low SBP (o160 mmHg) group there was no relationship between PWV and collagen concentrations. However, in the X160 mmHg group there was significant correlation between PWV and PIIINP concentration. The relationship held significant after adjustment for age, and BP components. Our result can help explaining the results of recent intervention trials where older patients tended to benefit more from potentially antifibrotic drugs (ACE-I), whereas those with compliant arteries tend to benefit from diuretics.
Introduction
Vascular stiffening, a process ascribed both to advancing age and high levels of blood pressure (BP), is in part associated with increased synthesis and deposition of collagen, both in arterial walls and left ventricle. At the level of myocardium it leads to hypertrophy, increased fibrosis, and impeded diastolic function -all independently associated with increase in the risk of death. 1, 2 From the perspective of the large artery, remodelling increases its wall thickness (thickening of media), and rigidity leading to a faster transmission of pressure pulse (as measured by pulse wave velocity (PWV)) along the arterial tree.
3, 4 This, in turn increases systolic blood pressure (SBP) and pulse pressure (PP) and contributes to increase in risk of cardiovascular complications especially in older hypertensive patients with isolated systolic hypertension. 5 However, in younger hypertensives with predominantly diastolic hypertension the data on the relationship between the arterial stiffness and risk profile are conflicting. 6, 7 Vascular stiffening has been partially attributed to changes in collagen synthesis. It has been hypothesized that some of the markers of collagen turnover, especially the N-terminal procollagen type III propeptide (PIIINP), and C-terminal procollagen type I propeptide (PICP) concentrations could follow the extent of pathological changes in heart and blood vessels, yet whether this might be true irrespective of age and level of pressure, has not been sufficiently studied. [4] [5] [6] The objective of our study was to check whether arterial stiffness is equally related to increased fibrotic remodelling as measured with PIIINP and PICP concentrations, in female patients with high (at or above 160 mmHg) and 'low' (below that value) SBP.
Methods

Patients
The data used in the analysis were obtained as a part of routine work-up of hypertensive individuals, carried out at our department. Consecutive treated hypertensive patients were eligible for this analysis if they had expressed their consent for their clinical data to be anonymously used for scientific purposes, completed the vascular measurements and were free from any of the following conditions that by involvement of fibrotic process in their pathogenesis could influence the levels of collagen markers: hepatitis and hepatic cirrhosis, pulmonary fibrosis, sarcoidosis, diseases of thyroid, rheumatoid arthritis, Paget's bone disease, and malignancies.
Blood pressure
Sitting BPs were measured twice in each patient with a standard sphygmomanometer according to the current guidelines. 8 In short, office sitting BP values have been obtained with a standard mercury sphygmomanometer. Patients had to be seated in a calm environment for at least 5 min prior to the measurement. BPs were initially measured on both arms to exclude significant deviations between values obtained on right and left arm. In case of an arm's SBP exceeding that measured on opposite arm by more than 10 mmHg, we used the arm with higher values for all subsequent BP recordings. Otherwise, in majority of cases, we used the values obtained on nondominant arm. Throughout the analysis we use the mean of two office BP values.
PWV
The PWV between carotid and femoral arteries was measured with the Complior device (Colson, France), after 15 min of rest in a recumbent position.
The probes were concomitantly applied to right common carotid and right femoral arteries. The computer algorithm calculated the pulse wave delay time (DT), and based on the length (L) between the measurement sites the PWV was calculated according to the formula: PWV ¼ L/DT (m/s).
Collagen
The assessment of collagen was performed from serum samples obtained after centrifugation of blood drawn from brachial vein. The samples before the measurements were stored for up to 6 months at À201C.
The commercially available radioimmunoassay kits (Orion Diagnostica, Espoo, Finland) were used to quantitatively ascertain the concentrations of PIIICP and PICP.
Statistical analysis
Means were compared using the Student's t-test. Then Pearson's correlation analysis was performed to assess the relationship between individual variables, first in the entire group and then in the subgroups according to SBP level. In the final step we fitted multiple linear regression equations where PWV was modelled as a function of respective markers of collagen synthesis in SBP subgroups.
Results
Group characteristics
The studied group comprised 100 women treated for hypertension, whose characteristics are given in Table 1 . The average age was 71.8710.5 years. The average SBP was 145725 mmHg, average diastolic BP was 83715 mmHg, the PP averaged 63717 mmHg, and mean BP (MBP) 104717 mmHg. PWV was 12.97 3.6 m/s and was significantly higher among 30 patients with SBP of 160 mmHg or more (Table 2) . The concentrations of the markers of collagen synthesis were 4.671.7 ng/ml for PIIINP and 142.27 47.0 ng/ml for PICP.
Relationship between PWV and studied factors
In the next step of the analysis, the PWV was correlated with age, BP components, markers of collagen synthesis, serum cholesterol and glucose, first in the entire group (Table 2 ) and then according to SBP level. In the group with SBP below the cutoff value (160 mmHg), PWV positively correlated with age (r ¼ 0.48, Po0.01), and PP (r ¼ 0.39, Po0.001).
In group with higher values of SBP, PWV was positively related exclusively to the concentration of PIIINP (r ¼ 0.53, Po0.01).
Multivariate linear regression analysis
In this step, we constructed the regression models with adjustment for age and MBP, to study the independent relationship between PWV and collagen synthesis markers. (Figures 1 and 2 ).
In the group with SBP below 160 mmHg, after adjustment, significant relationship was not found between either PIIINP or PICP and PWV. In both models PWV was strongly predicted by age (Table 3) .
On the contrary, in patients with high SBP, after adjustment for age, and MBP, PWV was independently predicted by PIIINP (b ¼ 1.1370.4, Po0.01) but not by PICP concentrations. The same was true when adjustment was made for PP instead of MBP.
Discussion
A new and innovative finding of this study was that in a series of medically treated hypertensive, periand postmenopausal women, the concentration of collagen metabolite PIIINP correlated with pulse wave velocity (PWV -an index of arterial stiffening) only in those with high SBP equal or exceeding 160 mmHg, but not in hypertensive women with diastolic hypertension. This was independent of patients' MBP. However, there was no relationship between the serum concentrations of PICP -an index of collagen type I synthesis, and vascular stiffening measured with PWV, regardless of the type of BP elevation.
Number of studies linked the serum collagen concentrations with the degree of stiffening in structures building-up the cardiovascular system, especially one influenced by hypertensive disease.
9,10 Vascular rigidity is patophysiologically linked to high SBP and low diastolic BP thus increasing the PP. 7, 11, [12] [13] [14] Hypertensive patients with left ventricular hypertrophy have been found to express cardiovascular fibrosis to a significantly higher degree. 15 This fibrotic process was measured by high production and low turnover of collagen type I. 16 Animal studies investigating into the collagen component in the build-up of large arterial walls revealed that the predominant form of this protein was collagen type III. 17 On the contrary, in human aortas the ratio is reverse, and an in vitro study seemed to indicate that it does not change across different ages. 18 Essential hypertensive patients develop cardiovascular fibrosis predominantly due to collagen type III accumulation. This in turn seems to be secondary to decrease in collagen degradation 19 and production. 20 The implications for development of rearrangements in cardiovascular (predominantly left ventricular) structure and function, have been studied to some extent. 20 Authors, who investigated the issue across three different rat strains, have found collagen type III to be most closely related to fibrotic changes. 21 Vascular stiffening as measured with various modalities and in different groups of patients has been linked to increased risk of cardiovascular morbidity and mortality. PP has been found to be independent marker of cardiovascular risk. 7, 22 This turned out to be especially true of the elderly patients with isolated systolic hypertension where SBP had to be 160 mmHg or higher. Studies both in hypertensive patients, patients with diabetes mellitus, and end-stage renal disease showed the prognostic value of PWV.
Our study must be interpreted within the context of its limitations.
Our subjects are consecutive outpatients, and can hardly stand for a randomly drawn sample. However, including real-life patients may paradoxically increase the generalisability of our findings onto populations of patients with similar characteristics. We decided to base our analysis on the SBP criterion, rather than traditionally dividing patients according to isolated systolic and mixed (systolodiastolic) hypertension. However, our patients are women of peri-and (mostly) postmenopausal age, an age-range where SBP seems to carry most prognostic information associated with BP, 23 and diastolic BP tends to be reversly associated with the risk, stressing the importance of arterial stiffness and hence PP. Medical treatment of ISH is a highly effective intervention saving lives and preventing major disability. 24 Two large-scale intervention trials proved that both thiazide diuretics 25 and long-acting dihydropiridines, 26 when needed combined with beta blockers or ACE-I have beneficial effect. In our study, we found a relationship between stiffening and collagen production in patients with elevated SBP but not those with predominantly diastolic form of hypertension. Drugs interfering with reninangiotensin-aldosterone system like the angiotensin-converting enzyme inhibitors or spironolactone have well-established potency to reduce collagen synthesis. Some of the recent trials (ANBPII, Hope) 27, 28 employing ACE-I to some extent confirm the importance of antifibrotic treatment. In our opinion, this stands against the idea of dull uniformisation of initial antihypertensive therapy. Based on our findings, we hypothesize that elderly patients with isolated systolic hypertension whose large arteries are stiff, and in whom stiffening is associated with increased fibrosis should benefit to a high degree from ACE-I-based antihypertensive treatment. However, further intervention studies including patients with isolated systolic, and systolo-diastolic hypertension, should elucidate this issue in a prespecified manner ( PIIINP found to be related with increased stiffness (PWV) in periand postmenopausal women with SBP X160 mmHg Type III collagen increased in vessels in hypertensives 9 Left ventricular hypertrophy and stiffness related to increased serum concentrations of type I and III collagen metabolites 20 No relation between stiffness and PICP found Positive relation between PWV and PICP in hypertensives. Both PWV and PICP decrease upon treatment with an ACE-I 29 PIIINP, N-terminal procollagen type III propeptide; PICP, C-terminal procollagen type I propeptide; PWV, pulse wave velocity; SBP, systolic blood pressure.
